| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
140,990,000 |
| Market
Cap: |
73.88(M) |
| Last
Volume: |
2,041,307 |
Avg
Vol: |
1,748,484 |
| 52
Week Range: |
$0.2971 - $1.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sangamo BioSciences is a clinical-stage genomic medicine company focused on translating science into medicines. Co.'s clinical-stage product candidates are: Isaralgagene civaparvovec (ST-920), which is Co.'s wholly-owned gene therapy product candidate for the treatment of Fabry disease; SAR445136, which is Co.'s zinc finger nuclease gene-edited cell therapy product candidate for the treatment of sickle cell disease; TX200 for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and Giroctocogene fitelparvovec (SB-525), which is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,784 |
| Total Buy Value |
$0 |
$0 |
$0 |
$25,029 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
6,000,000 |
6,500,000 |
| Total Sell Value |
$0 |
$0 |
$3,000,000 |
$5,657,240 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
3 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-04-13 |
4 |
OE |
$14.07 |
$114,853 |
D/D |
8,163 |
22,788 |
|
- |
|
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
• – – |
2018-04-06 |
4 |
AS |
$17.41 |
$87,065 |
D/D |
(5,000) |
8,125 |
|
- |
|
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
• – – |
2018-04-06 |
4 |
OE |
$3.20 |
$16,000 |
D/D |
5,000 |
13,125 |
|
- |
|
| Mento Steven J |
Director |
– • – |
2018-04-02 |
4 |
AS |
$18.39 |
$132,758 |
D/D |
(7,215) |
11,832 |
|
- |
|
| Mento Steven J |
Director |
– • – |
2018-04-02 |
4 |
OE |
$7.77 |
$77,700 |
D/D |
10,000 |
19,047 |
|
- |
|
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-04-02 |
4 |
AS |
$18.30 |
$41,684 |
D/D |
(2,278) |
14,625 |
|
- |
|
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-04-02 |
4 |
OE |
$3.50 |
$12,199 |
D/D |
2,278 |
16,903 |
|
- |
|
| Yi Kathy |
SVP & Chief Financial Officer |
• – – |
2018-03-15 |
4 |
AS |
$25.56 |
$127,812 |
D/D |
(5,000) |
7,250 |
|
- |
|
| Yi Kathy |
SVP & Chief Financial Officer |
• – – |
2018-03-15 |
4 |
OE |
$4.55 |
$22,750 |
D/D |
5,000 |
12,250 |
|
- |
|
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
• – – |
2018-03-06 |
4 |
AS |
$24.78 |
$123,878 |
D/D |
(5,000) |
8,125 |
|
- |
|
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
• – – |
2018-03-06 |
4 |
OE |
$3.20 |
$16,000 |
D/D |
5,000 |
13,125 |
|
- |
|
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-03-01 |
4 |
AS |
$23.06 |
$345,861 |
D/D |
(15,000) |
14,625 |
|
- |
|
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-03-01 |
4 |
OE |
$3.50 |
$147,905 |
D/D |
15,000 |
29,625 |
|
- |
|
| Mento Steven J |
Director |
– • – |
2018-03-01 |
4 |
AS |
$23.27 |
$219,546 |
D/D |
(9,433) |
9,047 |
|
- |
|
| Mento Steven J |
Director |
– • – |
2018-03-01 |
4 |
OE |
$5.03 |
$82,350 |
D/D |
15,000 |
18,480 |
|
- |
|
| Ramasastry Saira |
Director |
– • – |
2018-02-26 |
4 |
S |
$24.88 |
$235,080 |
D/D |
(9,450) |
0 |
|
- |
|
| Ramasastry Saira |
Director |
– • – |
2018-02-26 |
4 |
OE |
$5.03 |
$47,534 |
D/D |
9,450 |
9,450 |
|
- |
|
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
• – – |
2018-02-06 |
4 |
AS |
$18.49 |
$92,436 |
D/D |
(5,000) |
8,125 |
|
- |
|
| Conner Edward R. |
Sr. VP & Chief Medical Officer |
• – – |
2018-02-06 |
4 |
OE |
$3.20 |
$16,000 |
D/D |
5,000 |
13,125 |
|
- |
|
| Mento Steven J |
Director |
– • – |
2018-02-01 |
4 |
AS |
$20.59 |
$237,159 |
D/D |
(11,520) |
3,480 |
|
- |
|
| Mento Steven J |
Director |
– • – |
2018-02-01 |
4 |
OE |
$6.41 |
$133,750 |
D/D |
15,000 |
15,000 |
|
- |
|
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-02-01 |
4 |
AS |
$20.59 |
$308,855 |
D/D |
(15,000) |
14,625 |
|
- |
|
| Herberts Curt A. Iii |
Sr.VP & Chief Business Officer |
• – – |
2018-02-01 |
4 |
OE |
$3.50 |
$52,500 |
D/D |
15,000 |
29,625 |
|
- |
|
| Macrae Sandy |
President and CEO |
• • – |
2018-01-24 |
4 |
D |
$11.10 |
$44,111 |
D/D |
(3,974) |
27,526 |
|
- |
|
| Yi Kathy |
SVP & Chief Financial Officer |
• – – |
2018-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
7,250 |
7,250 |
|
- |
|
1106 Records found
|
|
Page 12 of 45 |
|
|
0.04 (6.83%) 
